Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Pharma Mar S.A (MC: PHM)

 
PHM Technical Analysis
4
As on 6th Nov 2025 PHM STOCK Price closed @ 71.90 and we RECOMMEND Buy for LONG-TERM with Stoploss of 64.19 & Strong Buy for SHORT-TERM with Stoploss of 36.63 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PHMSTOCK Price

Open 71.50 Change Price %
High 73.05 1 Day 1.05 1.48
Low 70.95 1 Week -1.80 -2.44
Close 71.90 1 Month -14.90 -17.17
Volume 87093 1 Year 34.06 90.01
52 Week High 101.40 | 52 Week Low 31.82
 
MC Spain Most Active Stocks
TEF 3.64 0.28%
SAN 8.94 0.68%
SAB 3.33 1.52%
BBVA 17.93 1.64%
UNI 2.49 2.47%
IAG 4.71 -2.48%
IBE 17.77 -0.06%
CABK 9.27 1.76%
EWT 63.30 %
MAP 3.98 0.76%
 
MC Spain Top Gainers Stocks
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
ADL 0.19 5.56%
EAT 3.48 2.96%
 
MC Spain Top Losers Stocks
CDR 0.09 -30.77%
CDR 0.09 -30.77%
CDR 0.09 -30.77%
CDR 0.09 -30.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
MED 0.69 -19.77%
 
 
PHM
Daily Charts		 PHM
Intraday Charts		 Whats New @
Bazaartrend		 PHM
Free Analysis
 
PHM Important Levels Intraday
RESISTANCE75.95
RESISTANCE74.65
RESISTANCE73.85
RESISTANCE73.04
SUPPORT70.76
SUPPORT69.95
SUPPORT69.15
SUPPORT67.85
 
PHM Forecast November 2025
Share
4th UP Forecast88.9
3rd UP Forecast83.45
2nd UP Forecast80.08
1st UP Forecast76.71
1st DOWN Forecast67.09
2nd DOWN Forecast63.72
3rd DOWN Forecast60.35
4th DOWN Forecast54.9
 
PHM Weekly Forecast
4th UP Forecast79.84
3rd UP Forecast77.29
2nd UP Forecast75.72
1st UP Forecast74.15
1st DOWN Forecast69.65
2nd DOWN Forecast68.08
3rd DOWN Forecast66.51
4th DOWN Forecast63.96
 
PHM Forecast2025
4th UP Forecast214.46
3rd UP Forecast168.74
2nd UP Forecast140.48
1st UP Forecast112.22
1st DOWN Forecast31.58
2nd DOWN Forecast3.32
3rd DOWN Forecast-24.94
4th DOWN Forecast-70.66
 
 
PHM Other Details
Segment EQ
Market Capital 1266828160.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PHM Address
PHM
 
PHM Latest News
 
Your Comments and Response on Pharma Mar S.A
 
PHM Business Profile
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops clinical-stage programs, including PM184 and PM14. In addition, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain. Address: Avenida de los Reyes, 1, Madrid, Spain, 28770
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service